Pinnacle Financial Partners Inc Laboratory Corp Of America Holdings Transaction History

Pinnacle Financial Partners Inc

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 30, 2024	BUY	$209.01 - $232.56 $240,361 - $267,444	1,150 Added 2.78%	42,501 $9.28 Million
Q4 2023 Jan 22, 2024	SELL	$197.69 - $227.29 $24,118 - $27,729	-122 Reduced 0.29%	41,351 $9.4 Million
Q3 2023 Nov 03, 2023	BUY	$201.05 - $221.7 $14,274 - $15,740	71 Added 0.17%	41,473 $8.34 Million
Q2 2023 Aug 07, 2023	SELL	$211.93 - $241.33 $1,907 - $2,171	-9 Reduced 0.02%	41,402 $9.99 Million
Q1 2023 Apr 26, 2023	BUY	$213.32 - $257.83 $648,919 - $784,318	3,042 Added 7.93%	41,411 $9.5 Million
Q4 2022 Feb 03, 2023	SELL	$203.72 - $248.97 $17,927 - $21,909	-88 Reduced 0.23%	38,369 $9.03 Million
Q3 2022 Oct 31, 2022	BUY	$204.81 - $262.19 $119,404 - $152,856	583 Added 1.54%	38,457 $7.88 Million
Q2 2022 Jul 29, 2022	SELL	$213.86 - $277.87 $3,421 - $4,445	-16 Reduced 0.04%	37,874 $8.88 Million
Q1 2022 May 02, 2022	BUY	$259.82 - $298.18 $6,495 - $7,454	25 Added 0.07%	37,890 $9.99 Million
Q4 2021 Feb 01, 2022	BUY	$271.6 - $314.21 $1.07 Million - $1.23 Million	3,925 Added 11.56%	37,865 $11.9 Million
Q3 2021 Oct 26, 2021	BUY	$274.82 - $308.34 $9.33 Million - $10.5 Million	33,940 New	33,940 $9.55 Million

1.94M

Ticker LH
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 89,600,000
Market Cap $20.6B
Description
Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...

Get notified when there are updates to the investment portfolio of Pinnacle Financial Partners Inc, based on Form 13F filings with the SEC.

Stay updated on Pinnacle Financial Partners Inc with notifications on news.